PlexusDx genetic testing results, interpreted alongside baseline metabolic markers and tolerance history, may help your provider tailor semaglutide dosing to your unique physiology
Clinical eligibility for GLP-1 drugs was determined using BMI and the following comorbidities as specified in NHIS: coronary heart disease, prior stroke, prior heart attack, angina, high blood pressure, and high cholesterol
Mitophagy, as a very crucial part of the mitochondrial control system, plays a special role in ischemic heart disease, unlike mitochondrial dynamics
doi:10.2337/dc22-1148 Dore DD, Seeger JD, Chan KA
You have COVID, you have this inflammatory hit to your system
Offering two innovative packages: COMPOUNDED GLP-1 + B 12 COMPOUNDED GLP-1/GIP + B3 Dive into the details of our offerings and discover how we can support your weight loss journey